Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. ZCMD
ZCMD logo

ZCMD Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.782
Open
1.640
VWAP
1.68
Vol
29.04K
Mkt Cap
6.69M
Low
1.530
Amount
48.92K
EV/EBITDA(TTM)
--
Total Shares
3.84M
EV
-5.33M
EV/OCF(TTM)
--
P/S(TTM)
2.05
Zhongchao Inc is a holding company engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public in China. The Company operates its businesses through two segments. MDMOOC Services segment engages in the provision of training and education services and assistance in patient-aid projects. Sales of Patented Drugs segment mainly engages in the sales of patented drugs. Under the MDMOOC brand, the Company offers a wide range of online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content to healthcare professionals as well as the public.
Show More

Events Timeline

(ET)
2026-02-26
08:50:00
Zhongchao to Effectuate 1-for-8 Share Consolidation
select

News

seekingalpha
8.5
02-26seekingalpha
Zhongchao Announces 1-for-8 Share Consolidation
  • Share Consolidation Plan: Zhongchao announced a 1-for-8 share consolidation effective March 2, 2026, reducing its ordinary shares from 25.75 million Class A and 4.99 million Class B to approximately 3.21 million Class A and 624,972 Class B shares, thereby decreasing the total share count and potentially increasing per-share value.
  • Exchange Continuation: Post-consolidation, Class A shares will continue trading on Nasdaq under the same symbol 'ZCMD', a move aimed at enhancing market liquidity and attractiveness, although it may have a short-term negative impact on stock price.
  • Current Capital Structure: Prior to the consolidation, the company has issued 25.75 million Class A and 4.99 million Class B shares, and the significant reduction in outstanding shares could alter the investor holding structure and market perception.
  • Market Reaction: Following the consolidation announcement, ZCMD's premarket trading price fell by 8.055% to $0.2203, indicating market concerns regarding the share consolidation and its potential impact on investor confidence and future financing capabilities.
PRnewswire
8.5
02-26PRnewswire
Zhongchao Inc. Announces 1-for-8 Share Consolidation
  • Share Consolidation Plan: Zhongchao Inc. announced a 1-for-8 share consolidation effective March 2, 2026, aimed at consolidating every eight ordinary shares into one to regain compliance with Nasdaq Rule 5550(a)(2), thereby maintaining its listing on the Nasdaq Capital Market.
  • Impact on Shares: Post-consolidation, the company will have approximately 3,219,267 Class A ordinary shares and 624,972 Class B ordinary shares, significantly down from 25,754,124 Class A and 4,999,772 Class B shares, indicating efforts to optimize its capital structure.
  • Shareholder Rights Protection: The consolidation will uniformly affect all shareholders, ensuring that no shareholder's percentage interest in the company's ordinary shares is altered, except for adjustments due to fractional shares, thus maintaining shareholder stability.
  • Board Approval: The share consolidation plan was approved by the company's shareholders and board of directors on February 10, 2026, reflecting management's confidence in the company's future development and commitment to market compliance.
Benzinga
9.5
02-05Benzinga
Align Technology Reports Strong Q4 Earnings Beat
  • Earnings Beat: Align Technology reported Q4 earnings of $3.29 per share, surpassing analyst expectations of $2.97, indicating a significant improvement in profitability and boosting market confidence in future growth.
  • Sales Growth: The company achieved quarterly sales of $1.047 billion, exceeding the consensus estimate of $1.033 billion, demonstrating robust performance amid strong market demand.
  • Stock Surge: Align's shares jumped 10.4% in pre-market trading to $178.13, reflecting a positive investor reaction to the financial results, which may attract more investor interest.
  • Increased Market Confidence: This earnings beat not only enhances Align's market image but also potentially supports its future investment and expansion plans, further solidifying its leadership position in the industry.
Benzinga
8.5
2025-12-31Benzinga
FuelCell Energy Files for $200 Million Stock Offering, Shares Drop 8.9%
  • Stock Offering: FuelCell Energy announced an amended sales agreement to increase the total amount of shares available for sale to $200 million, which led to an 8.9% drop in share price to $7.23 on Wednesday, indicating a negative market reaction to the dilution of shares.
  • Market Reaction: The announcement of the stock offering raised investor concerns, as the significant drop in share price could impact the company's future fundraising capabilities and market confidence, particularly in the current economic climate where investors are sensitive to equity dilution.
  • Funding Purpose: FuelCell Energy plans to use the proceeds from this offering to support its R&D and operational expenditures, and while the stock faces short-term pressure, successful fundraising could provide the necessary capital to drive technological innovation and market expansion in the long run.
  • Industry Impact: In the context of increasing competition in the hydrogen and fuel cell industry, FuelCell Energy's stock offering may affect its reputation among investors, especially as the effectiveness of its financing strategy will directly influence its market position compared to other competitors.
Benzinga
8.5
2025-12-30Benzinga
OceanFirst Financial Corp. Announces $579 Million All-Stock Acquisition of Flushing, Shares Drop 7.4%
  • Acquisition Announcement: OceanFirst Financial Corp. has announced a $579 million all-stock acquisition of Flushing Financial, which aims to enhance market share, yet the stock price fell 7.4%, indicating a negative market reaction to the deal.
  • Market Reaction: Following the acquisition news, OceanFirst's shares dropped to $18.15, reflecting investor uncertainty regarding integration risks and potential returns, which may impact the company's short-term capital flow.
  • Strategic Implications: This acquisition represents OceanFirst's strategic move to expand its presence in the New Jersey market, potentially increasing its customer base and long-term profitability, although short-term stock volatility may undermine investor confidence.
  • Investor Focus: As the acquisition progresses, the market will closely monitor how OceanFirst manages the integration process and its impact on financial performance, especially in the current economic climate where investors are cautious about the banking sector.
NASDAQ.COM
2.0
2025-10-02NASDAQ.COM
ZCMD, ABCL, VOR, IXHL, OVID, BFRG Surge in After-Hours Trading Due to Clinical Progress and Recent Developments
  • Biotech Stocks Surge: Several biotech and healthcare stocks experienced significant after-hours gains on October 1, driven by technical momentum and recent clinical updates, despite the absence of new filings or press releases.

  • Zhongchao Inc. and AbCellera Biologics: Zhongchao Inc. saw a 14.04% increase after hours, while AbCellera Biologics rose 11.41%, both benefiting from prior trial data and analyst commentary rather than new announcements.

  • Vor Biopharma and Incannex Healthcare: Vor Biopharma rebounded 9.53% after a previous drop, and Incannex Healthcare gained 6.48%, with both companies relying on earlier clinical trial results to influence trading.

  • Ovid Therapeutics and Bullfrog AI Holdings: Ovid Therapeutics shares rose 8.03% following a positive earnings report, while Bullfrog AI Holdings advanced 3.44% after announcing an expansion of its sales and marketing team.

Valuation Metrics

The current forward P/E ratio for Zhongchao Inc (ZCMD.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Zhongchao Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Whales Holding ZCMD

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Zhongchao Inc (ZCMD) stock price today?

The current price of ZCMD is 1.74 USD — it has increased 7.41

What is Zhongchao Inc (ZCMD)'s business?

Zhongchao Inc is a holding company engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public in China. The Company operates its businesses through two segments. MDMOOC Services segment engages in the provision of training and education services and assistance in patient-aid projects. Sales of Patented Drugs segment mainly engages in the sales of patented drugs. Under the MDMOOC brand, the Company offers a wide range of online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content to healthcare professionals as well as the public.

What is the price predicton of ZCMD Stock?

Wall Street analysts forecast ZCMD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ZCMD is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Zhongchao Inc (ZCMD)'s revenue for the last quarter?

Zhongchao Inc revenue for the last quarter amounts to NaN USD, decreased

What is Zhongchao Inc (ZCMD)'s earnings per share (EPS) for the last quarter?

Zhongchao Inc. EPS for the last quarter amounts to USD, decreased

How many employees does Zhongchao Inc (ZCMD). have?

Zhongchao Inc (ZCMD) has 111 emplpoyees as of March 10 2026.

What is Zhongchao Inc (ZCMD) market cap?

Today ZCMD has the market capitalization of 6.69M USD.